Clinical Trials in Minneapolis

Showing 2481-2500 of 14,456 trials

Full-mouth Electronic Toothbrush vs. Conventional Electronic Toothbrush

NCT06561204

The goal of this randomized, masked-examiner clinical trial is to investigate a full-mouth electronic toothbrush (FMET). The three arms are: 1) FMET + American Dental Association (ADA) approved dentifrice, 2) conventional electronic toothbrush (ETB) + ADA dentifrice and 3) FMET + foam system.

ToothbrushGingivitisPlaque

University of Minnesota94 participantsStarted Dec 2024

Minneapolis, Minnesota, United States

SUSPENDEDNA< 1 mile

Cleansing Device for the Treatment of Scalp and Hair Conditions

NCT05319444

The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.

DandruffSeborrheic DermatitisHair Loss

University of Minnesota40 participantsStarted May 2026

Minneapolis, Minnesota, United States

COMPLETEDPhase 3< 1 mile

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

NCT04977986

This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of Cannabidiol administered as ZYN002 for the treatment of children, adolescent, and young adult patients with Fragile X Syndrome (FXS). Eligible participants will participate in up to an 18-week treatment period, where all participants will receive placebo or active study drug. Patients ages 3 to \< 30 years will be eligible to participate.

Fragile X Syndrome

Zynerba Pharmaceuticals, Inc.215 participantsStarted Sep 2021

Phoenix, Arizona, United States • Culver City, California, United States • Irvine, California, United States +24 more locations

Full-mouth Electronic Toothbrush vs. Conventional Electronic Toothbrush

Cleansing Device for the Treatment of Scalp and Hair Conditions

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

Find Trials by Condition in Minneapolis

The PorchLight Project

Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

NATIENS: Optimal Management and Mechanisms of SJS/TEN

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer